Navigation Links
Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women
Date:10/28/2009

IRVINE, Calif., Oct. 28 /PRNewswire/ -- Although Breast Cancer Awareness Month is coming to an end, smart women know that taking care of their health is important throughout the year. What's more, women age 25 and older now have a tool to help them understand their potential risk for breast cancer. Based on the same science as the PAP test for cervical cell changes, HALO® is the only FDA-cleared risk assessment tool for non-hereditary breast cancer. HALO can help identify women at increased risk for breast cancer years before a lump might appear, allowing for clinical intervention aimed at prevention and early detection.

It is estimated that 11,000 breast cancer diagnoses occur each year in women under the age of 40 who are too young for mammograms, and that 85% of women diagnosed with the condition have no direct family history of the disease. Yet all too often, women rely solely on mammograms and breast exams to detect abnormal tissue or believe they are not at risk if they do not have breast cancer in their family.

"Before HALO, it was very difficult to collect cells from the breast ducts that might help us identify women who are at risk for developing breast cancer, particularly women too young for mammography," said Alison L. Laidley MD, FACS, FRCS(C), of Breast Surgeons of North Texas. "HALO may help physicians identify women who need close monitoring or perhaps further testing because they are at increased risk."

Screening for abnormal cells (also called atypia) with HALO can help women and their doctors identify precancerous changes, closely monitor them and develop an optimal care path aimed at prevention. Women found to have atypia are four-to-five times more likely to develop breast cancer in the future.

HALO is designed as a complement to mammography and breast exams, the current standard screening for breast cancer. HALO is not a replacement for current routine screening with breast exams and mammograms. HALO is recommended annually for women over age 25. It is especially helpful for women who are too young for mammograms, or whose mammograms are less effective due to dense breast tissue that can obscure the detection of lesions.

HALO combines warmth, massage and suction to bring nipple aspirate fluid (NAF) to the surface. NAF is found in the milk ducts where virtually all invasive breast cancers originate. The test takes five minutes and is easily incorporated into a typical well-woman visit. The sample is then sent to the lab and analyzed for any cellular abnormalities.

"As a dedicated breast specialist, I believe that women should take a proactive role in understanding their breast healthcare. This proactive process can happen by encouraging women to ask questions and discuss options for risk assessment, screening and prevention with their doctors," said Dr. Laidley.

About NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fluid for cytological evaluation for the determination and/or differentiation of normal versus pre-malignant versus malignant cells. For further information, visit www.neomatrix.com.

SOURCE NeoMatrix, LLC


'/>"/>
SOURCE NeoMatrix, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
3. Do Women Have a Right to a Breastpump That Works? Asks Hygeia
4. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
5. Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
6. Capecitabine Added to Standard Treatment Given Before Surgery Helps to Eradicate Tumours in Patients With Early Breast Cancer
7. Medications Effective in Reducing Risk of Breast Cancer But Increase Risk of Adverse Effects, New Report Says
8. New stem cell identification technology could cure breast cancer
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk
11. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... /PRNewswire/ - Demers Ambulances announces its first delivery in the state ... County Emergency Medical Services (EMS) consisting of four ... van. Quality Emergency Vehicles in Lecanto, FL ... This is the latest in Demers, ongoing expansion of sales.  ... Demers. --> Benoit LaFortune , Executive Vice President ...
(Date:2/12/2016)... Feb. 12, 2016   HeartWare International, Inc . ... and webcast to discuss its financial results for the ... Thursday, February 25, 2016 at 8:00 a.m. ET.  The ... the conference call and webcast.  On the conference call ... highlights from the fourth quarter and business outlook.   ...
(Date:2/12/2016)... Kalifornien, 12. Februar 2016  Sequent Medical, Inc. ... von Patienten für eine Studie zur Sicherheit und ... speziell für die Behandlung von rupturierten intrakraniellen Aneurysmen ... Leiter der Neuroradiologie an der Universitätsklinik Bicètre in ... der CLARYS-Studie hat den ersten Patienten aufgenommen. ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... With FCPX Overlay Embers from Pixel Film Studios users can now apply ... user can select from up to 40 effect overlays. With FCPX Overlay Embers users ... value, contrast, glow, and more all within a click of a mouse. , ...
(Date:2/13/2016)... , ... February 13, 2016 , ... ... of Nursing with an in-kind gift of a VeinViewer® Vision vein finder ... they learn how to start an IV and draw blood, combining technology with ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... ... Tech Outlook’s top Clinical Data Management Solution Providers list for its expertise in ... functional and domain expertise to serve the technology needs of global clients. DDi ...
(Date:2/12/2016)... ... February 12, 2016 , ... The law firm of Morrow, Morrow, Ryan ... The purpose of these scholarships is to encourage applicants to pursue a degree in ... within these two parishes. , “We have available jobs in St. Landry and ...
(Date:2/12/2016)... Falls Church, VA (PRWEB) , ... February 12, 2016 , ... CDRH Enforcement Trends: , ... http://www.fdanews.com/cdrhenforcementtrends , As Winston Churchill said, “Those who don’t learn ... 2015 will show what to expect when they come knocking this year. But that takes ...
Breaking Medicine News(10 mins):